NEXENTIS TECHNOLOGIES INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $2.38 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-31
- NEXENTIS TECHNOLOGIES INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $2.38M, a 69.44% increase from fiscal 2024.
- NEXENTIS TECHNOLOGIES INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.40M, a 55.18% increase from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $904.75K, a 39.25% decline from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $1.49M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $2.38M 10-K · filed 2026-03-31 |
| 2024-12-31 | $1.40M 10-K · filed 2025-03-31 |
| 2023-12-31 | $904.75K 10-K · filed 2024-04-01 |
| 2022-12-31 | $1.49M 10-K · filed 2023-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |